GlassScriptPhysician profile
Naili Duan
NPI 1700802311
$14,140.10
in general payments reported to CMS, 2019-2025
59 companies · $1,991 in 2025
The $1,991 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,966 · 2020: $795 · 2021: $1,592 · 2022: $2,180 · 2023: $2,649 · 2024: $2,967 · 2025: $1,991.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,606.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,606.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,800.19 | 2019-2025 | Duopa, Botox, Ubrelvy |
| Ucb, INC. | $1,472.03 | 2019-2025 | Briviact, Zilbrysq, Nayzilam |
| Neurocrine Biosciences, INC. | $906.65 | 2019-2025 | Ingrezza, Ongentys |
| Biogen, INC. | $718.35 | 2019-2025 | Vumerity, Tysabri, Skyclarys |
| Lilly USA, LLC | $697.78 | 2019-2025 | Amyvid, Kisunla, Emgality |
| Amgen INC. | $552.44 | 2019-2022 | |
| Amneal Pharmaceuticals LLC | $518.71 | 2019-2025 | Rytary, Crexont, Ongentys 50mg Capsules 30 |
| Teva Pharmaceuticals USA, INC. | $488.34 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Emd Serono, INC. | $475.87 | 2019-2025 | Mavenclad |
| Mdd US Operations, LLC | $471.11 | 2019-2025 | Gocovri, Gocovri, Qelbree |
| Novartis Pharmaceuticals Corporation | $413.33 | 2019-2024 | |
| Acadia Pharmaceuticals INC | $357.61 | 2019-2025 | Nuplazid |
| Argenx US, INC. | $336.53 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Supernus Pharmaceuticals, INC. | $328.05 | 2019-2024 | Qelbree |
| Acorda Therapeutics, INC | $306.11 | 2019-2023 | Inbrija |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $272.56 | 2019-2022 | |
| Lundbeck LLC | $260.88 | 2020-2025 | Vyepti |
| Otsuka America Pharmaceutical, INC. | $248.13 | 2023-2025 | Rexulti, Nuedexta |
| Boston Scientific Corporation | $231.38 | 2022-2024 | |
| Kyowa Kirin, INC. | $205.92 | 2020-2025 | Nourianz |
| Genentech USA, INC. | $201.98 | 2019-2024 | Ocrevus, Enspryng, Ocrevus Zunovo |
| Allergan, INC. | $196.56 | 2019-2021 | |
| Alnylam Pharmaceuticals INC. | $188.16 | 2022-2024 | Onpattro |
| Eisai INC. | $167.13 | 2020-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $165.08 | 2022 | |
| Pfizer INC. | $161.01 | 2023-2025 | |
| Avion Pharmaceuticals | $132.06 | 2022-2023 | Dhivy |
| Neurelis, INC. | $112.34 | 2021-2024 | Valtoco |
| Sumitomo Pharma America, INC. | $112.10 | 2023-2024 | Aptiom |
| Merz Pharmaceuticals, LLC | $108.44 | 2024-2025 | Inbrija, Xeomin |
| Avanir Pharmaceuticals, INC. | $99.50 | 2019-2020 | |
| Alkermes, INC. | $92.75 | 2019 | |
| Upsher-Smith Laboratories LLC | $92.54 | 2019-2022 | |
| Aucta Pharmaceuticals, INC. | $91.32 | 2025 | Motpoly Xr |
| Grifols USA, LLC | $89.34 | 2019-2025 | Gamunex-C |
| Tanabe Pharma America, INC. | $78.78 | 2019 | |
| Janssen Biotech, INC. | $77.73 | 2025 | |
| Biohaven Pharmaceuticals, INC. | $73.11 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $72.80 | 2020-2022 | |
| Sk Life Science, INC. | $65.51 | 2023-2025 | |
| Catalyst Pharmaceuticals, INC. | $59.11 | 2023 | Firdapse |
| Jazz Pharmaceuticals INC. | $56.58 | 2021-2022 | |
| Corium, LLC | $50.86 | 2022-2023 | Adlarity |
| Genzyme Corporation | $49.48 | 2019-2022 | |
| Vanda Pharmaceuticals INC. | $48.48 | 2024-2025 | Ponvory |
| Insightec,INC | $45.42 | 2024-2025 | Exablate |
| Mallinckrodt Hospital Products INC. | $43.59 | 2022-2024 | Acthar |
| Horizon Therapeutics Plc | $43.55 | 2022-2023 | Uplizna |
| Janssen Pharmaceuticals, INC | $42.62 | 2022 | |
| Adamas Pharmaceuticals, INC. | $42.25 | 2019-2021 | |
| Celgene Corporation | $33.99 | 2022-2023 | Zeposia |
| Averitas Pharma INC. | $30.63 | 2024 | Qutenza |
| Livanova USA, INC. | $30.62 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Abbott Laboratories | $24.03 | 2025 | Infinity |
| Microtransponder, INC. | $21.18 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.77 | 2019 | |
| Impel Pharmaceuticals INC. | $20.54 | 2023 | Trudhesa |
| Alexion Pharmaceuticals, INC. | $19.69 | 2019 | |
| Medtronic USA, INC. | $16.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naili Duan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.